INmune Bio Inc (INMB) — Cash Flow Quality Index
Latest as of December 2025:
-0.07x
INmune Bio Inc (INMB) has a Cash Flow Quality Index of -0.07x as of December 2025. Operating cash flow of $-2.96 Million is below net income of $40.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore INmune Bio Inc (INMB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.07x
Operating CF / Net Income
Operating Cash Flow
$-2.96 Million
USD
Net Income
$40.75 Million
USD
Data as of
Dec 2025
Most recent filing
Annual Cash Flow Quality Index for INmune Bio Inc (None–None)
Year-by-year earnings quality comparison for INmune Bio Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.